Please assess the completion status of the following clinical trial:

Trial Title: Spinal Cord Stimulation to Treat Post-operative Atrial Fibrillation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Patients which will be subjected to an OFF-pump CABG procedure~2. More than 18 years of age~3. Subject is able and willing to give informed consent.~Exclusion Criteria:~1. Patients with known history of atrial arrhythmias.~2. Patients who are not treated with β-blockers unless heart rate is too low for β-blockers assumption.~3. Participation in another clinical trial which may affect the outcome within 3 months prior to day of procedure.~4. Other surgical interventions (e.g. valve replacement) programmed in the same surgical session~5. Resting pulse rate ≤45 beats / min as assessed before daily doses of β-blockage is administered.~6. Hypotension (RR systolic \<100 or RR diastolic \<50).~7. Conduction abnormalities on the ECG consisting of a 1st degree atrioventricular block or a complete bundle branch block.~8. Subject is diagnosed with epilepsy or history of seizures.~9. Coagulation abnormalities as determined by anticoagulation guidelines for neuroaxial procedures 2011.~10. Patients not stabilized on an anti-arrhythmic drug regimen for the last 30 days.~11. Patients with long QT syndrome.~12. Patients with Brugada syndrome.~13. Patients affected by Polyneuropathy (e.g. due to diabetes).~14. Patients affected by pericarditis~15. Patients who underwent procedures in the past, which are expected to have changed the innervation of the heart for example:~    * Ablation procedure~   * Cardiac surgery~16. Pregnant patients or nursing (subjects who are of child bearing potential and are not on a reliable form of birth control will undergo a pregnancy test)~17. Patients already implanted with cardiac devices~18. Patients with existing implanted neurostimulators

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Conventional treatment (Type: OTHER): Non interventional group, patients that belong to this arm will receive the conventional treatment for CABG and they will wear the Holter for 5 days.
- Spinal Cord Stimulation System (Type: EXPERIMENTAL): This group will receive the Spinal Cord Stimulation System and they will wear the Holter for 5 days.

Based on this trial design, predict the completion outcome and termination type (if applicable).